PET in uterine malignancies

HTML  Download Download as PDF (Size: 108KB)  PP. 652-660  
DOI: 10.4236/health.2010.27099    6,732 Downloads   11,188 Views  

Affiliation(s)

.

ABSTRACT

Positron Emission Tomography (PET) or integrated PET/Computed Tomography (PET/CT) with 18F-Fluoro-Deoxy-Glucose (18F-FDG) is a functional imaging modality, useful in the characterization of undetermined morphological findings, and in the staging/re-staging of a large number of malignancies. Although its use in uterine malignancies has been poorly investigated, in recent years the employment of this technique has constantly increased. In this review, we evaluate the role of PET (/CT) with 18FFDG in uterine malignancies (cervical and endometrial cancers as well as uterine sarcomas), underlying its advantages and discussing its limitations. Metabolic and anatomic information given by PET/CT with 18F-FDG could be useful in the evaluation of local and distant disease involvement at the staging, in the detection of disease recurrence, and in the evaluation of the response after chemotherapy and/or radio-therapy.

Share and Cite:

Pirro, V. , Skanjeti, A. and Pelosi, E. (2010) PET in uterine malignancies. Health, 2, 652-660. doi: 10.4236/health.2010.27099.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.